Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05642000 · ClinicalTrials.gov registry record · NA

The Safer At School Early Alert HUB

A NA study of COVID-19, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
1,029
Enrollment target
1
Study location

NCT05642000: Completed NA study of COVID-19, sponsored by University of California, San Diego.

NCT05642000 is a NA study of COVID-19 that has completed, run by University of California, San Diego. The registered enrollment target is 1,029 participants, below the 38,461-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05642000, a NA study of COVID-19, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
1,029 participants
Enrollment target
1
Study location

Study Summary

Schools serve important community roles beyond academic education. In historically marginalized communities they are trusted providers for a range of support services for families in need. The tradeoff between these crucial benefits of in-person learning against the risk of SARS-CoV-2 transmission in school settings has been hotly debated throughout much of 2020 and 2021. The stakes are particularly high in historically marginalized communities which rely most heavily on school services, but have also been hit the hardest by COVID-19 primarily due to structural issues. The Safer at School Early Alert (SASEA) program was co-developed by the University of California, San Diego, the County of San Diego, and 15 partner schools serving socially vulnerable students in 5 school districts across San Diego County. SASEA utilizes daily wastewater and surface (floor) environmental monitoring to detect asymptomatic SARS-CoV-2 infections among students and staff on campus. Positive environmental signals are immediately followed by targeted responsive testing for a whole school (in the case of wastewater) or classroom (for a positive surface sample). In this project, we will develop the Safer at School Early Alert HUB (SASEA HUB), an online school environmental monitoring report dashboard with resources to address structural barriers to COVID-19 diagnostic testing in historically marginalized communities (Aim 1). We will also create a toolkit to allow any school to rapidly adapt the template to their specific setting. In Aims 2 and 3, we will use a randomized stepped wedge trial to compare SASEA (control) vs SASEA HUB (intervention) in 26 schools across 3 diverse school clusters in San Diego County. Our primary outcome (Aim 2) is higher rates of diagnostic testing in intervention schools. Our secondary outcome (Aim 3) is increased risk mitigation behaviors in school community members when environmental surveillance data suggests a potential case on campus. In Aim 4, we will use p

Primary Outcome

The primary study endpoint will be student diagnostic testing uptake in the previous 14-days, measured using household surveys distributed at 2-week intervals.

Conditions Studied

Interventions

  • BEHAVIORAL SASEA HUB

Study Locations (1)

California

  • University of California, San Diego - San Diego

Trial Details

FieldValue
Enrollment Target 1,029 participants
Start Date 2022-09-19
Est. Completion 2022-12-17
Phase NA
University of California, San Diego

775 total trials

What the finished NCT05642000 record still lists

NCT05642000 is an interventional study that assigns participants to a tested intervention. Its 1,029 participants enrollment target places it among the larger protocols in the corpus, below the 38,461-participant average among 298 other COVID-19 trials with a reported enrollment target (97% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which SASEA HUB is the first listed.

NCT05642000 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05642000 about?

NCT05642000 is a clinical study titled "The Safer At School Early Alert HUB". Schools serve important community roles beyond academic education. In historically marginalized communities they are trusted providers for a range of support services for families in need. The tradeoff between these crucial benefits of in-person learning against the risk of SARS-CoV-2 transmission i...

What is the current status of trial NCT05642000?

This trial is currently completed. It is a NA study. The enrollment target is 1,029 participants. The study started on 2022-09-19. Estimated completion is 2022-12-17.

What conditions does trial NCT05642000 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT05642000?

The interventions under investigation include: SASEA HUB (BEHAVIORAL).

Who is sponsoring clinical trial NCT05642000?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05642000 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05642000's enrollment target sits among peer trials

1,029 68th of 298 higher than 231 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06080698 · 1,030 participants · NA

    Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

  • NCT07084363 · 1,032 participants · NA

    Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

  • NCT02200276 · 1,025 participants · NA

    Influenza Immunization in Adults Over Age 75

  • NCT02296450 · 1,025 participants

    Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05642000, the US trial registry maintained by the National Library of Medicine. NCT05642000 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.